Virology, Immunology, Virus, Hepatitis C virus and Viremia are her primary areas of study. As part of her studies on Virology, Susan L. Stramer often connects relevant subjects like Risk factor. Her study ties her expertise on Internal medicine together with the subject of Immunology.
Her work on Viral replication as part of her general Virus study is frequently connected to SNP, thereby bridging the divide between different branches of science. Her study in Hepatitis C virus is interdisciplinary in nature, drawing from both Nucleic acid amplification technique, Chikungunya and Prevalence, Incidence. Her Incidence research is multidisciplinary, incorporating elements of Serology, Blood donations and Confidence interval.
Susan L. Stramer mostly deals with Virology, Immunology, Antibody, Virus and Serology. She works mostly in the field of Virology, limiting it down to concerns involving Blood transfusion and, occasionally, Transmission and Epidemiology. Her Immunology study incorporates themes from Disease and Risk factor.
Her study in Antibody is interdisciplinary in nature, drawing from both Infectivity, Antigen and Polymerase chain reaction. In general Virus, her work in Flavivirus and Flaviviridae is often linked to Human T-lymphotropic virus linking many areas of study. Her Serology research incorporates elements of Infectious disease, Internal medicine, Chagas disease and Trypanosoma cruzi.
Her primary areas of investigation include Virology, Antibody, Internal medicine, Serology and Donation. Her biological study spans a wide range of topics, including RNA, Nat and Donor selection. Her Antibody study is associated with Immunology.
Her research on Immunology often connects related topics like Trypanosoma cruzi. Her Internal medicine study combines topics in areas such as Blood donor and Outbreak. Her study looks at the relationship between Serology and topics such as Viral load, which overlap with Transmission.
Her primary areas of study are Antibody, Virology, Severe acute respiratory syndrome coronavirus 2, Immunology and Zika virus. Her study looks at the relationship between Antibody and fields such as Donor selection, as well as how they intersect with chemical problems. Her Virology research includes elements of Antigen and Coronavirus disease 2019.
Her studies in Severe acute respiratory syndrome coronavirus 2 integrate themes in fields like Symptom onset and Serology. Susan L. Stramer frequently studies issues relating to Contamination and Immunology. She has researched Zika virus in several fields, including Antibody-dependent enhancement, Dengue virus, Nucleic Acid Testing, Viral load and Flavivirus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
New Testing Strategy to Detect Early HIV-1 Infection for Use in Incidence Estimates and for Clinical and Prevention Purposes
Robert S. Janssen;Glen A. Satten;Susan L. Stramer;Bhupat D. Rawal.
Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population.
R.Y. Dodd;E.P. Notari;S.L. Stramer.
Transmission of West Nile virus through blood transfusion in the United States in 2002.
Lisa N. Pealer;Anthony A. Marfin;Lyle R. Petersen;Robert S. Lanciotti.
The New England Journal of Medicine (2003)
Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing
Susan L. Stramer;Simone A. Glynn;Steven H. Kleinman;D. Michael Strong.
The New England Journal of Medicine (2004)
A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors.
Michael P. Busch;Simone A. Glynn;Susan L. Stramer;D. Michael Strong.
Emerging infectious disease agents and their potential threat to transfusion safety
Susan L. Stramer;F. Blaine Hollinger;Louis M. Katz;Steven Kleinman.
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity
Susana V. Bardina;Paul Bunduc;Shashank Tripathi;James Duehr.
Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis
Alexander L. Greninger;Samia N. Naccache;Scot Federman;Guixia Yu.
Genome Medicine (2015)
Nucleic Acid Testing to Detect HBV Infection in Blood Donors
Susan L. Stramer;Ulrike Wend;Daniel Candotti;Gregory A. Foster.
The New England Journal of Medicine (2011)
The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations
Brian R. Jackson;M. P. Busch;S. L. Stramer;J. P. AuBuchon.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: